Inventor · disambiguated record
Michael Stefanidakis
Also filed as: STEFANIDAKIS MICHAEL
7 granted patents·5 pending applications·30 citations·filing 2004–2023
81Inventor score
Top patents by PatentIndex Score
12 records- 0190US9051365B2Antibodies that bind factor PNOVARTIS AG·Filed 2012·Granted Jun 9, 2015·18 cites·11 claims
- 0285US11339437B2Compositions and methods for treating CEP290-associated diseaseEDITAS MEDICINE INC·Filed 2017·Granted May 24, 2022·3 cites·117 claims
- 0384US11566263B2Compositions and methods for treating CEP290 associated diseaseEDITAS MEDICINE INC·Filed 2017·Granted Jan 31, 2023·3 cites·28 claims
- 0479US11524998B2Anti-betacellulin antibodies, fragments thereof, and multi-specific binding moleculesNOVARTIS AG·Filed 2021·Granted Dec 13, 2022·2 cites·20 claims
- 0578US11141493B2Compositions and methods for treating CEP290-associated diseaseEDITAS MEDICINE INC·Filed 2018·Granted Oct 12, 2021·2 cites·35 claims
- 0674US9988440B2Compositions comprising antibodies targeting factor PNOVARTIS AG·Filed 2014·Granted Jun 5, 2018·2 cites·33 claims
- 0770US2024141386A1Compositions and methods for treating cep290 associated diseaseEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 0868US2022273818A1Compositions and methods for treating cep290-associated diseaseEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 0968US2023295725A1Compositions and methods for treating cep290-associated diseaseEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 1064US10865237B2Nucleic acids encoding anti-Factor P antibodiesNOVARTIS AG·Filed 2018·Granted Dec 15, 2020·0 cites·11 claims
- 1155US2023038993A1Compositions and methods for treating cep290-associated diseaseEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 1235US2007099839A1Inhibitors of cell migrationCIT CANCER TARGETING TECHNOLOG·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Stefanidakis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →